Holger Willenbring, MD, PhD

Title(s)Professor, Surgery
SchoolSchool of Medicine
Address35 Medical Center Way
San Francisco CA 94143
Phone415-476-2417
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Next-generation human liver gene therapy
    NIH DP1DK130689Sep 30, 2021 - Jun 30, 2026
    Role: Principal Investigator
    Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
    NIH UH3DK120004Sep 20, 2018 - Jul 31, 2023
    Role: Co-Principal Investigator
    Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
    NIH UG3DK120004Sep 20, 2018 - Jul 31, 2020
    Role: Co-Principal Investigator
    Targeting AAV vectors to cell types involved in alcohol-induced liver injury
    NIH R01AA026578Sep 1, 2018 - May 31, 2023
    Role: Principal Investigator
    Building a functional biliary system from hepatocytes
    NIH R01DK107553Sep 1, 2016 - Jul 31, 2021
    Role: Co-Principal Investigator
    Myofibroblast-to-hepatocyte conversion as a therapy for alcoholic liver disease
    NIH R21AA022158Sep 1, 2013 - Aug 31, 2016
    Role: Principal Investigator
    Liver regeneration with stems cells of uniparental origin
    NIH R01DK080852Apr 1, 2008 - Aug 31, 2013
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reply to "The Role of Aquaporin 9 in Modeling of Ornithine Transcarbamylase Deficiency". Hepatology. 2021 Dec 21. Laemmle A, Häberle J, Willenbring H. PMID: 34935158.
      View in: PubMed   Mentions:
    2. Aquaporin 9 Induction in Human iPSC-derived Hepatocytes Facilitates Modeling of Ornithine Transcarbamylase Deficiency. Hepatology. 2021 Nov 16. Laemmle A, Poms M, Hsu B, Borsuk M, Rüfenacht V, Robinson J, Sadowski MC, Nuoffer JM, Häberle J, Willenbring H. PMID: 34786702.
      View in: PubMed   Mentions:
    3. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction. Front Pharmacol. 2021; 12:667010. Lee-Montiel FT, Laemmle A, Charwat V, Dumont L, Lee CS, Huebsch N, Okochi H, Hancock MJ, Siemons B, Boggess SC, Goswami I, Miller EW, Willenbring H, Healy KE. PMID: 34025426.
      View in: PubMed   Mentions: 4  
    4. Induced Pluripotent Stem Cell-derived Hepatocytes From Patients With Nonalcoholic Fatty Liver Disease Display a Disease-specific Gene Expression Profile. Gastroenterology. 2021 Jun; 160(7):2591-2594.e6. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Duwaerts CC, Le Guillou D, Her CL, Phillips NJ, Willenbring H, Mattis AN, Maher JJ. PMID: 33640436; PMCID: PMC8169560.
      View in: PubMed   Mentions:    Fields:    
    5. Emerging cell therapy for biliary diseases. Science. 2021 02 19; 371(6531):786-787. Kurial SNT, Willenbring H. PMID: 33602846.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Transcriptomic Traces of Adult Human Liver Progenitor Cells. Hepatology. 2020 04; 71(4):1504-1507. Kurial SNT, Willenbring H. PMID: 31991483.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration. Cell Stem Cell. 2020 01 02; 26(1):27-33.e4. Chen F, Jimenez RJ, Sharma K, Luu HY, Hsu BY, Ravindranathan A, Stohr BA, Willenbring H. PMID: 31866223.
      View in: PubMed   Mentions: 31     Fields:    Translation:Cells
    8. Hepatocyte Nuclear Factor 4 Alpha Activation Is Essential for Termination of Liver Regeneration in Mice. Hepatology. 2019 08; 70(2):666-681. Huck I, Gunewardena S, Espanol-Suner R, Willenbring H, Apte U. PMID: 30520062.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    9. De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation. Nature. 2018 05; 557(7704):247-251. Schaub JR, Huppert KA, Kurial SNT, Hsu BY, Cast AE, Donnelly B, Karns RA, Chen F, Rezvani M, Luu HY, Mattis AN, Rougemont AL, Rosenthal P, Huppert SS, Willenbring H. PMID: 29720662.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    10. Postnatal Organogenesis by Transdifferentiation. The FASEB Journal. 2018 Apr 1; 32:240.3-240.3. Willenbring WH. .
      View in: Publisher Site   Mentions:
    11. Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference. J Gastrointest Oncol. 2016 Dec; 7(6):819-827. Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, Kelley RK, Kwong LN, Lowery M, Merrell A, Miyabe K, Rhim A, Saha S, Sia D, Tanasanvimon S, Venook A, Valle JW, Walesky C, Whetstine J, Willenbring H, Zhu AX, Mayer D, Stanger BZ. PMID: 28078106.
      View in: PubMed   Mentions: 7  
    12. In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis. Cell Stem Cell. 2016 06 02; 18(6):809-816. Rezvani M, Español-Suñer R, Malato Y, Dumont L, Grimm AA, Kienle E, Bindman JG, Wiedtke E, Hsu BY, Naqvi SJ, Schwabe RF, Corvera CU, Grimm D, Willenbring H, Rezvani M, Español-Suñer R, Malato Y, Dumont L, Grimm AA, Kienle E, Bindman JG, Wiedtke E, Hsu BY, Naqvi SJ, Schwabe RF, Corvera CU, Grimm D, Willenbring H. PMID: 27257763; PMCID: PMC5325707.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    13. Assessing the therapeutic potential of lab-made hepatocytes. Hepatology. 2016 07; 64(1):287-94. Rezvani M, Grimm AA, Willenbring H, Rezvani M, Grimm AA, Willenbring H. PMID: 27014802; PMCID: PMC5316561.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    14. Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha. Hepatology. 2016 07; 64(1):261-75. Desai SS, Tung JC, Zhou VX, Grenert JP, Malato Y, Rezvani M, Español-Suñer R, Willenbring H, Weaver VM, Chang TT, Desai SS, Tung JC, Zhou VX, Grenert JP, Malato Y, Rezvani M, Español-Suñer R, Willenbring H, Weaver VM, Chang TT. PMID: 26755329; PMCID: PMC5224931.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    15. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology. 2015 Jan; 61(1):141-52. Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E, Koliwad S, Lim LP, Maher JJ, Raffai RL, Willenbring H, Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E, Koliwad S, Lim LP, Maher JJ, Raffai RL, Willenbring H. PMID: 25131933; PMCID: PMC4465779.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    16. AAV8-mediated in vivo overexpression of miR-155 enhances the protective capacity of genetically attenuated malarial parasites. Mol Ther. 2014 12; 22(12):2130-2141. Hentzschel F, Hammerschmidt-Kamper C, Börner K, Heiss K, Knapp B, Sattler JM, Kaderali L, Castoldi M, Bindman JG, Malato Y, Willenbring H, Mueller AK, Grimm D, Hentzschel F, Hammerschmidt-Kamper C, Börner K, Heiss K, Knapp B, Sattler JM, Kaderali L, Castoldi M, Bindman JG, Malato Y, Willenbring H, Mueller AK, Grimm D. PMID: 25189739; PMCID: PMC4429697.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    17. Evidence against a Stem Cell Origin of New Hepatocytes in a Common Mouse Model of Chronic Liver Injury. Cell Reports. 2014 Sep 1; 8(5):1607. Schaub SJ, Malato MY, Gormond GC, Willenbring WH. .
      View in: Publisher Site   Mentions:
    18. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep. 2014 Aug 21; 8(4):933-9. Schaub JR, Malato Y, Gormond C, Willenbring H, Schaub JR, Malato Y, Gormond C, Willenbring H. PMID: 25131204; PMCID: PMC4376310.
      View in: PubMed   Mentions: 112     Fields:    Translation:AnimalsCells
    19. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins). Transplant Proc. 2014 Jul-Aug; 46(6):2002-6. Lee RH, Roll G, Nguyen V, Willenbring H, Tang Q, Kang SM, Stock PG, Lee RH, Roll G, Nguyen V, Willenbring H, Tang Q, Kang SM, Stock PG. PMID: 25131094; PMCID: PMC5262438.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    20. Brief report: Parthenogenetic embryonic stem cells are an effective cell source for therapeutic liver repopulation. Stem Cells. 2014 Jul; 32(7):1983-8. Espejel S, Eckardt S, Harbell J, Roll GR, McLaughlin KJ, Willenbring H, Espejel S, Eckardt S, Harbell J, Roll GR, McLaughlin KJ, Willenbring H. PMID: 24740448; PMCID: PMC4376534.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    21. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. Hepatology. 2014 Aug; 60(2):554-64. Ng R, Wu H, Xiao H, Chen X, Willenbring H, Steer CJ, Song G, Ng R, Wu H, Xiao H, Chen X, Willenbring H, Steer CJ, Song G. PMID: 24677249; PMCID: PMC4809671.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    22. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature. 2014 Apr 03; 508(7494):93-7. Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ, Willenbring H, Ding S, Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ, Willenbring H, Ding S. PMID: 24572354; PMCID: PMC4161230.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansAnimalsCells
    23. Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 2014; 9(6). Mitchell C, Willenbring H, Mitchell C, Willenbring H. PMID: 24874817.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    24. Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem Cell Res Ther. 2013; 4 Suppl 1:S14. Mathur A, Loskill P, Hong S, Lee J, Marcus SG, Dumont L, Conklin BR, Willenbring H, Lee LP, Healy KE, Mathur A, Loskill P, Hong S, Lee J, Marcus SG, Dumont L, Conklin BR, Willenbring H, Lee LP, Healy KE. PMID: 24565415; PMCID: PMC4029618.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    25. MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology. 2014 Jan; 59(1):202-15. Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, Willenbring H, Dupuy A, Chen X, Brown D, Chang AN, Goga A, Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, Willenbring H, Dupuy A, Chen X, Brown D, Chang AN, Goga A. PMID: 23913442; PMCID: PMC3877416.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    26. Transplantable liver organoids made from only three ingredients. Cell Stem Cell. 2013 Aug 01; 13(2):139-40. Willenbring H, Soto-Gutierrez A, Willenbring H, Soto-Gutierrez A. PMID: 23910079; PMCID: PMC3828077.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    27. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Transl Med. 2013 Jun; 2(6):409-19. Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, Nolta JA, Willenbring H, Zern MA, Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, Nolta JA, Willenbring H, Zern MA. PMID: 23681950; PMCID: PMC3673753.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    28. A therapy for liver failure found in the JNK yard. Cell. 2013 Apr 11; 153(2):283-4. Willenbring H, Grompe M, Willenbring H, Grompe M. PMID: 23582318; PMCID: PMC4169283.
      View in: PubMed   Mentions:    Fields:    
    29. Akt/Notch activation drives rapid cholangiocarcinoma development originating from mature hepatocytes in the mouse. Zeitschrift für Gastroenterologie. 2013 Jan 11; 51(01). Evert EM, Fan FB, Malato MY, Ribback RS, Dombrowski DF, Willenbring WH, Chen CX, Calvisi CD. .
      View in: Publisher Site   Mentions:
    30. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest. 2012 Aug; 122(8):2911-5. Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, Gores GJ, Dombrowski F, Evert M, Chen X, Willenbring H, Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, Gores GJ, Dombrowski F, Evert M, Chen X, Willenbring H. PMID: 22797301; PMCID: PMC3408746.
      View in: PubMed   Mentions: 161     Fields:    Translation:HumansAnimalsCells
    31. A ZFN/piggyBac step closer to autologous liver cell therapy. Hepatology. 2012 Jun; 55(6):2033-5. Mattis AN, Willenbring H, Mattis AN, Willenbring H. PMID: 22422378.
      View in: PubMed   Mentions: 1     Fields:    
    32. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest. 2012 Mar; 122(3):1097-108. Ng R, Song G, Roll GR, Frandsen NM, Willenbring H, Ng R, Song G, Roll GR, Frandsen NM, Willenbring H. PMID: 22326957; PMCID: PMC3287214.
      View in: PubMed   Mentions: 70     Fields:    Translation:AnimalsCells
    33. Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology. 2012 Jan; 55(1):298-306. Rountree CB, Mishra L, Willenbring H, Rountree CB, Mishra L, Willenbring H. PMID: 22030746; PMCID: PMC3245372.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    34. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest. 2011 Dec; 121(12):4850-60. Malato Y, Naqvi S, Schürmann N, Ng R, Wang B, Zape J, Kay MA, Grimm D, Willenbring H, Malato Y, Naqvi S, Schürmann N, Ng R, Wang B, Zape J, Kay MA, Grimm D, Willenbring H. PMID: 22105172; PMCID: PMC3226005.
      View in: PubMed   Mentions: 159     Fields:    Translation:AnimalsCells
    35. A simple code for installing hepatocyte function. Cell Stem Cell. 2011 Aug 05; 9(2):89-91. Willenbring H, Willenbring H. PMID: 21816357.
      View in: PubMed   Mentions: 7     Fields:    
    36. Mouse chimeras as a system to investigate development, cell and tissue function, disease mechanisms and organ regeneration. Cell Cycle. 2011 Jul 01; 10(13):2091-9. Eckardt S, McLaughlin KJ, Willenbring H, Eckardt S, McLaughlin KJ, Willenbring H. PMID: 21606677; PMCID: PMC3230469.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    37. Core promoter recognition complex changes accompany liver development. Proc Natl Acad Sci U S A. 2011 Mar 08; 108(10):3906-11. D'Alessio JA, Ng R, Willenbring H, Tjian R, D'Alessio JA, Ng R, Willenbring H, Tjian R. PMID: 21368148; PMCID: PMC3054039.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    38. The MAP3K TAK1: a chock block to liver cancer formation. Hepatology. 2010 Oct; 52(4):1506-9. Malato Y, Willenbring H, Malato Y, Willenbring H. PMID: 20879030.
      View in: PubMed   Mentions: 6     Fields:    
    39. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest. 2010 Sep; 120(9):3120-6. Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, Okita K, Yamanaka S, Willenbring H, Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, Okita K, Yamanaka S, Willenbring H. PMID: 20739754; PMCID: PMC2929736.
      View in: PubMed   Mentions: 65     Fields:    Translation:AnimalsCells
    40. Transplanted nonviable human hepatocytes produce appreciable serum albumin levels in mice. Stem Cell Res. 2010 Nov; 5(3):267-70. Roll GR, Willenbring H, Roll GR, Willenbring H. PMID: 20829142.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    41. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY). 2010 Jul; 2(7):415-31. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, Verdin E, Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, Verdin E. PMID: 20634564; PMCID: PMC2933889.
      View in: PubMed   Mentions: 110     Fields:    Translation:AnimalsCells
    42. Therapeutic liver reconstitution with murine cells isolated long after death. Gastroenterology. 2010 Sep; 139(3):1019-29. Erker L, Azuma H, Lee AY, Guo C, Orloff S, Eaton L, Benedetti E, Jensen B, Finegold M, Willenbring H, Grompe M, Erker L, Azuma H, Lee AY, Guo C, Orloff S, Eaton L, Benedetti E, Jensen B, Finegold M, Willenbring H, Grompe M. PMID: 20621682; PMCID: PMC3786690.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    43. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology. 2010 May; 51(5):1735-43. Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, Frandsen NM, Willenbring H, Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, Frandsen NM, Willenbring H. PMID: 20432256; PMCID: PMC3108060.
      View in: PubMed   Mentions: 85     Fields:    Translation:AnimalsCells
    44. Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell. 2008 Jul 08; 14(1):59-67. Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, Finegold M, Grompe M, Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, Finegold M, Grompe M. PMID: 18598944; PMCID: PMC2526059.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    45. ????????in vitro???. . 2008 Mar 1; 717-717. ??? ??, Kahn KJ, Willenbring WH, ?? ??, ?? ??, ?? ??. .
      View in: Publisher Site   Mentions:
    46. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 2008; 3(7):1167-70. Mitchell C, Willenbring H, Mitchell C, Willenbring H. PMID: 18600221.
      View in: PubMed   Mentions: 195     Fields:    Translation:AnimalsCells
    47. On the origin of the term "stem cell". Cell Stem Cell. 2007 Jun 07; 1(1):35-8. Ramalho-Santos M, Willenbring H, Ramalho-Santos M, Willenbring H. PMID: 18371332.
      View in: PubMed   Mentions: 45     Fields:    Translation:Cells
    48. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci U S A. 2006 Aug 29; 103(35):13156-61. Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, Grompe M, Fleming WH, Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, Grompe M, Fleming WH. PMID: 16920790; PMCID: PMC1559769.
      View in: PubMed   Mentions: 85     Fields:    Translation:AnimalsCells
    49. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci U S A. 2006 Apr 18; 103(16):6321-5. Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH, Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH. PMID: 16606845; PMCID: PMC1435365.
      View in: PubMed   Mentions: 99     Fields:    Translation:AnimalsCells
    50. Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases. Gastroenterology. 2006 Jan; 130(1):104-19. Vogel A, Aslan JE, Willenbring H, Klein C, Finegold M, Mount H, Thomas G, Grompe M, Vogel A, Aslan JE, Willenbring H, Klein C, Finegold M, Mount H, Thomas G, Grompe M. PMID: 16401474; PMCID: PMC1424224.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    51. Myeloid Lineage-Restricted Progenitors Contribute to Vascular Endothelium. Blood. 2005 Nov 16; 106(11):2267-2267. Bailey BA, Willenbring WH, Jiang JS, Schroeder SD, Anderson AD, Grompe GM, Wong WM, Fleming FW. .
      View in: Publisher Site   Mentions:
    52. In vivo genetic selection of renal proximal tubules. Mol Ther. 2006 Jan; 13(1):49-58. Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M, Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M. PMID: 16216560.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    53. Therapeutic cell fusion. Br J Surg. 2005 Aug; 92(8):923-4. Willenbring H, Willenbring H. PMID: 16034848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Delineating the hepatocyte's hematopoietic fusion partner. . 2004 Dec; 3(12):1489-91. Willenbring H, Grompe M, Willenbring H, Grompe M. PMID: 15611666.
      View in: PubMed   Mentions: 4  Translation:AnimalsCells
    55. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med. 2004 Jul; 10(7):744-8. Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M, Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M. PMID: 15195088.
      View in: PubMed   Mentions: 129     Fields:    Translation:AnimalsCells
    56. Embryonic versus adult stem cell pluripotency: in liver only fusion matters. J Assist Reprod Genet. 2003 Oct; 20(10):393-4. Willenbring H, Grompe M, Willenbring H, Grompe M. PMID: 14649377.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    57. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003 Apr 24; 422(6934):897-901. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M, Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M. PMID: 12665832.
      View in: PubMed   Mentions: 371     Fields:    Translation:AnimalsCells
    58. Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene. Hum Genet. 2002 Oct; 111(4-5):350-9. Linnebank M, Tschiedel E, Häberle J, Linnebank A, Willenbring H, Kleijer WJ, Koch HG, Linnebank M, Tschiedel E, Häberle J, Linnebank A, Willenbring H, Kleijer WJ, Koch HG. PMID: 12384776.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    59. Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet. 2000 Sep; 8(9):725-9. Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG, Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG. PMID: 10980581.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    60. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann Oncol. 1999 Jun; 10(6):715-21. Poremba C, Willenbring H, Hero B, Christiansen H, Schäfer KL, Brinkschmidt C, Jürgens H, Böcker W, Dockhorn-Dworniczak B, Poremba C, Willenbring H, Hero B, Christiansen H, Schäfer KL, Brinkschmidt C, Jürgens H, Böcker W, Dockhorn-Dworniczak B. PMID: 10442195.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    61. Telomerase activity in human proliferative breast lesions. Int J Oncol. 1998 Mar; 12(3):641-8. Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B, Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B. PMID: 9472105.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    62. Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency. J Clin Endocrinol Metab. 1996 Sep; 81(9):3415-8. Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zöllner A, Struve D, Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zöllner A, Struve D. PMID: 8784107.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    63. Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency. Eur J Pediatr. 1996 Jun; 155(6):445-51. Hiort O, Willenbring H, Albers N, Hecker W, Engert J, Dibbelt L, Sinnecker GH, Hiort O, Willenbring H, Albers N, Hecker W, Engert J, Dibbelt L, Sinnecker GH. PMID: 8789759.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Holger's Networks
    Concepts (287)
    Derived automatically from this person's publications.
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _